Body Compositional Changes in Cancer Cachexia
Marion F. Winkler
Abstract
Marion F. Winkler
Abstract
The cancer cachexia syndrome is characterized by profound changes in protein, fat, and carbohydrate metabolism, resulting in anorexia, weight loss, muscle wasting, and poor performance status. Many pharmacologic agents have been used to stimulate appetite and minimize weight loss, but few have been successful in promoting lean tissue accretion and enhancing muscle function. The purpose of this review was to investigate whether body composition can be changed with drug therapy or specific nutrient components. Multimodal strategies that include physical activity appear to be necessary to promote weight stabilization and lean body mass gain in patients with cancer cachexia.
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The cancer cachexia syndrome is characterized by profound changes in protein, fat, and carbohydrate metabolism, resulting in anorexia, weight loss, muscle wasting, and poor performance status. Many pharmacologic agents have been used to stimulate appetite and minimize weight loss, but few have been successful in promoting lean tissue accretion and enhancing muscle function. The purpose of this review was to investigate whether body composition can be changed with drug therapy or specific nutrient components. Multimodal strategies that include physical activity appear to be necessary to promote weight stabilization and lean body mass gain in patients with cancer cachexia.
Key concepts: Cachexia, Anorexia, Lean body mass, Wasting, Cancer cachexia, Appetite, Weight loss, Medicine